Alembic Pharmaceuticals Limited invests in Canadian Corporation to target pharmaceutical market
Alembic Pharmaceuticals Limited has announced a strategic investment through a Shareholders' Agreement aimed at establishing a dedicated platform for developing and marketing pharmaceutical products within the Canadian market. The investment is directed towards a newly incorporated Canadian Corporation (17989377 Canada Inc.).The agreement brings together Alembic Pharmaceuticals Limited, Difgen Holdings LLC, and Mr. Sukhad Juneja as the parties involved in the transaction. The primary purpose of entering into the Shareholders' Agreement is to establish this investment platform focused specifically on the needs of the Canadian market for...